<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03740438</url>
  </required_header>
  <id_info>
    <org_study_id>HCB/2016/0906/2</org_study_id>
    <nct_id>NCT03740438</nct_id>
  </id_info>
  <brief_title>Modeling of the Hemoglobin Drop in the Uncomplicated Postoperative Course</brief_title>
  <official_title>Modeling of the Hemoglobin Drop in the Uncomplicated Postoperative Course</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      transfusion-related decisions in the perioperative setting are often complex due to acute
      variations in the hemoglobin levels, which typically experience a progressive decrease within
      days. This process, commonly referred to as &quot;hemoglobin drop&quot; or &quot;hemoglobin drift&quot;, has been
      observed to be highly variable among patients and reliant on several variables, such as the
      volemic status, fluid balance and blood loss. Although it has been investigated and some
      predictors have been identified, postoperative hemoglobin drop remains unpredictable and is
      not fully clarified. In consequence, hemoglobin levels' variations are frequently
      misunderstood, hindering the decision to transfuse.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">November 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>4 Days</target_duration>
  <primary_outcome>
    <measure>Hemoglobin concentration</measure>
    <time_frame>2-5 days</time_frame>
    <description>PatientÂ´s hemoglobin concentration in the postoperative course (measured every 24 hours)</description>
  </primary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Surgical Blood Loss</condition>
  <condition>Surgery</condition>
  <condition>Perioperative/Postoperative Complications</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Hemoglobin concentration</intervention_name>
    <description>Perioperative hemogloin concentration</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients electively scheduled for laparoscopic urologic and gynecologic surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients electively scheduled for laparoscopic urologic and gynecologic surgery.

        Exclusion Criteria:

          -  Suspected or confirmed coagulopathy (including current treatment with anticoagulants
             or antiplatelet agents).

          -  Requirement for surgical gauzes during surgery, including conversion to open surgical
             techniques.

          -  Transfusion of red blood cells (RBCs) or use of blood recovery systems during the
             perioperative period.

          -  Significant postoperative bleeding (&gt; 50 ml in surgical drains, gross hematuria, or
             any other type of significant blood loss).

          -  Postoperative hemodynamic instability (defined as requirement of vasoactive drugs).

          -  Other major postoperative complications during the observable period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sebastian Jaramillo, MD</last_name>
    <phone>932275558</phone>
    <email>jaramillo@clinic.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Clinic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sebastian Jaramillo, MD</last_name>
      <email>jaramillo@clinic.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>November 5, 2018</study_first_submitted>
  <study_first_submitted_qc>November 11, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2018</study_first_posted>
  <last_update_submitted>August 5, 2019</last_update_submitted>
  <last_update_submitted_qc>August 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>Sebastian Jaramillo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Hemoglobin</keyword>
  <keyword>Hemoglobin drop</keyword>
  <keyword>Surgical Blood loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Blood Loss, Surgical</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

